1. Home
  2. BDSX vs FINW Comparison

BDSX vs FINW Comparison

Compare BDSX & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • FINW
  • Stock Information
  • Founded
  • BDSX 2005
  • FINW 1999
  • Country
  • BDSX United States
  • FINW United States
  • Employees
  • BDSX N/A
  • FINW N/A
  • Industry
  • BDSX Precision Instruments
  • FINW Commercial Banks
  • Sector
  • BDSX Health Care
  • FINW Finance
  • Exchange
  • BDSX Nasdaq
  • FINW Nasdaq
  • Market Cap
  • BDSX 215.3M
  • FINW 212.8M
  • IPO Year
  • BDSX 2020
  • FINW 2021
  • Fundamental
  • Price
  • BDSX $1.07
  • FINW $16.80
  • Analyst Decision
  • BDSX Strong Buy
  • FINW Buy
  • Analyst Count
  • BDSX 4
  • FINW 3
  • Target Price
  • BDSX $3.08
  • FINW $18.67
  • AVG Volume (30 Days)
  • BDSX 318.9K
  • FINW 15.2K
  • Earning Date
  • BDSX 02-28-2025
  • FINW 01-30-2025
  • Dividend Yield
  • BDSX N/A
  • FINW N/A
  • EPS Growth
  • BDSX N/A
  • FINW N/A
  • EPS
  • BDSX N/A
  • FINW 1.06
  • Revenue
  • BDSX $65,562,000.00
  • FINW $69,509,000.00
  • Revenue This Year
  • BDSX $46.97
  • FINW N/A
  • Revenue Next Year
  • BDSX $31.44
  • FINW $10.13
  • P/E Ratio
  • BDSX N/A
  • FINW $15.52
  • Revenue Growth
  • BDSX 48.92
  • FINW 4.87
  • 52 Week Low
  • BDSX $1.07
  • FINW $8.72
  • 52 Week High
  • BDSX $2.21
  • FINW $20.50
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 30.25
  • FINW 52.51
  • Support Level
  • BDSX $1.09
  • FINW $15.33
  • Resistance Level
  • BDSX $1.51
  • FINW $16.69
  • Average True Range (ATR)
  • BDSX 0.10
  • FINW 0.64
  • MACD
  • BDSX -0.04
  • FINW 0.11
  • Stochastic Oscillator
  • BDSX 0.00
  • FINW 80.77

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About FINW FinWise Bancorp

FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank also has established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.

Share on Social Networks: